Article Listing - US Corporate Results Round-Up

GOOD GROWTH FOR RHONE-POULENC

9 March 1992

At Rhone-Poulenc, "the aggressive marketing effort on promotion-responsive products, supplemented by a roll-out of at least eight new medium-sized drugs,...

NORTH AMERICA'S OTC COUGH COLD MARKET

9 March 1992

By Mick Maroney, manager, North American Region, at Nicholas Hall & Co

The cough and cold remedies market is now established...

PHARMA OFFSETS SHARP FALL AT AKZO

9 March 1992

The Dutch chemical and pharmaceutical group, Akzo, saw declines in 1991, but buoyant pharmaceuticals helped to offset poor results in...

NOWEDA FINED BY CARTEL OFFICE

9 March 1992

The German drug wholesaler, Noweda, has been fined 3.1 million Deutschemarks ($1.9 million) by the Federal Cartel Office (BKA) for...

NEW SINO-US PHARMA VENTURE IN CHINA

9 March 1992

An agreement has been signed between the Kumming Pharma-ceutical Factory and the Ivax Corp of the USA to establish Kumming...

RECORDATI SHARES EXCHANGE HANDS

9 March 1992

A 1.5% shareholding stake in the Italian pharmaceutical company Recordati changed hands on March 4 on Milan's wholesale bourse, according...

JAPAN URGES IL-2 AND PKU DRUG APPROVAL

9 March 1992

Japan's Central Pharmaceutical Affairs Council has urged the Public Health and Welfare Ministry to approve for manufacture and sale drugs...

TRIAL GO-AHEAD FOR DEPRENYL'S ALZENE

9 March 1992

Toronto, Canada-based Deprenyl Research Limited has received approval to test the putative anti-Alzheimer's disease drug alzene in humans at medical...

NEW LAB FOR AMERSHAM

9 March 1992

Amersham International reports that it has now extended its contract service for the preparation of radio-labelled biomedical molecules with the...

CAL BIO NAME CHANGE

9 March 1992

The US biotechnology company California Biotechnology has changed its name to Scios Inc. "In anticipation of bringing our pharmaceutical products...